# OnCo record neovax (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/neovax/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "neovax" ;
  schema:name "NeoVax"@en ;
  schema:alternateName "Personalised neoantigen peptide vaccine (Dana-Farber)"@en ;
  schema:description "NeoVax is a made-to-order vaccine: a patient's tumour is sequenced, the mutations most likely to be seen by the immune system are turned into peptides, and these are injected to train T cells against that tumour alone. Early trials in melanoma and glioblastoma showed it raises the intended immune response."@en ;
  schema:url <https://onco.cc/drugs/neovax/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  onco:status "phase-1" ;
  onco:tag "subtype-drugs-wave" ;
  onco:modality "Personalised neoantigen long-peptide vaccine with poly-ICLC adjuvant" ;
  onco:cancers <https://onco.cc/cancers/glioblastoma/> ;
  onco:institutions <https://onco.cc/institutions/dana-farber/> .